Forte Biosciences (FBRX) Shares Outstanding (Diluted Average) (2021 - 2023)

Forte Biosciences (FBRX) has 3 years of Shares Outstanding (Diluted Average) data on file, last reported at $21.0 million in Q2 2023.

• Shares Outstanding (Diluted Average) for Q2 2023 came in at $21.0 million, up 42.45% year-over-year; the trailing twelve-month figure through Jun 2023 was $21.0 million (up 42.45% YoY), and the FY2022 annual result was $17.4 million, up 24.45% from the prior year.
• Shares Outstanding (Diluted Average) steadied at $21.0 million in Q2 2023 per FBRX's latest filing, from $21.0 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $21.0 million in Q2 2023 and troughed at $13.4 million in Q2 2021.
• A 3-year average of $16.3 million and a median of $14.8 million in 2022 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Diluted Average) increased 9.92% in 2022, then jumped 42.45% in 2023.
• A 3-year view of Shares Outstanding (Diluted Average) shows it stood at $14.0 million in 2021, then rose by 24.45% to $17.4 million in 2022, then increased by 20.96% to $21.0 million in 2023.
• Business Quant data shows FBRX's Shares Outstanding (Diluted Average) at $21.0 million in Q2 2023, $21.0 million in Q1 2023, and $17.4 million in Q4 2022.